
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
EDITORIAL article
Front. Bioeng. Biotechnol., 01 September 2023
Sec. Nanobiotechnology
Volume 11 - 2023 | https://doi.org/10.3389/fbioe.2023.1282946
This article is part of the Research TopicBiomedical applications and health impacts of emerging nanostructured materialsView all 6 articles
Editorial on the Research Topic
Biomedical applications and health impacts of emerging nanostructured materials
Innovative nanostructures have been engineered for various biomedical applications, such as the diagnosis and therapy of diseases and the remediation of hazardous medical waste, presenting a transformative avenue for challenges in traditional biomedicine. While such bio-responsive exotic nanostructures may also have negative health impacts, it becomes crucial to simultaneously advance their biomedical applications while thoroughly investigate the health implications. With a specific focus on the latest advances in emerging nanostructures for biomedical applications and their health concerns, the Research Topic “Biomedical applications and health impacts of emerging nanostructured materials” records five articles including two Original Research articles, one Review, one Mini Review, and one Opinion.
The two Original Research articles highlight the medical applications of emerging metal-organic framework (MOF)-based nanostructures. Specifically, Yang et al. constructed an miR-200c-3p@ZIF-8 nanostructure in one step using a Y-shaped microfluidic chip for effective osteoarthritis treatment. At the cellular level, the authors verified that the ZIF-8 vectors had low cytotoxicity and high miRNA loading efficiency, and improved the cellular uptake and endosomal escape of miR-200c-3p, an osteoarthritis therapeutic microRNA. More importantly, the enhanced delivery and stable expression of miR-200c-3p suppressed the protein expression of various inflammatory cytokines in LPS-induced chondrocytes, confirming the promising application of this emerging nanostructure in the treatment of osteoarthritis. Taking ciprofloxacin as a typical medical waste, Geng et al. compared the degradation efficiencies of medical waste by four types of Fe-based MOFs with different structures to identify the key factors affecting the stability of the MOF structures during the peroxodisulfate activation processes. The authors reported that active species (i.e., OH· and SO4−·), oxidant reagent, and low pH negatively affected the stability of MOF structures, and the Fe(II)-MOFs exhibited the best stability performance among the tested nanostructures. This work provides a new insight into the future development of Fe-based MOFs for the remediation of hazardous medical waste.
Regarding the health concerns of the emerging nanostructures, Xuan et al. provided an updated overview of the key factors that modulate the biological effects of nanoparticles. In their review, the influences of not only the primary characterizations of particle size, shape, chemical composition, and surface modification, but also the secondary modifications with proteins on the biological effects of nanoparticles, were discussed. The most recent advances in the underlying mechanisms involved in nano-bio interactions were also summarized. In another Mini Review, Zhou et al. discussed the potential health risks of engineered nanoparticles, with a particular focus on their interference with pulmonary inflammation. According to the authors, certain nanoparticles themselves are likely to be inflammation inducers, causing or exacerbating the inflammatory responses in the lung. However, through careful engineering, they could also serve as vectors of anti-inflammatory drugs, posing therapeutic potentials for lung inflammation.
In addition, Zhang et al. contributed an Opinion article to this Research Topic, prospecting the potential application of nanotechnology in advanced cryopreservation of biological samples. In brief, the nanoparticle-assisted delivery methods have helped overcome the major limitation of the ultra-low permeability of impermeable cryoprotectants, and methods like nanowarming could help achieve rapid and uniform rewarming while avoiding the adverse effects of devitrification on biological samples. In cooperation with the novel automatic washing techniques, efficient and high-quality cryopreservation methods are expected to be realized in the near future.
Although this Research Topic encompasses several cutting-edge breakthroughs, the prevailing challenges persist. Developing innovative nanostructures to effectively address major challenges remains a top research strategy with significant implications for advanced biomedical applications. Besides, the need to tackle essential concerns related to the bioactivity, compatibility, and nano-bio interfacial properties of emerging nanostructures remains a prominent area that requires comprehensive investigation and resolution.
JJ: Funding acquisition, Writing–original draft, Writing–review and editing. QM: Funding acquisition, Writing–review and editing. HZ: Writing–review and editing.
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (22276042), the Guangdong Basic and Applied Basic Research Foundation (2023A1515012978), and the Talent Project of Guangzhou University (RC2023013). QM acknowledges funding support from the National Cancer Institute of NIH (R21CA273739).
We would like to thank all authors for their contributions to this Research Topic and we acknowledge the work of the reviewers whose constructive comments contributed to improving the quality of the articles.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: nanomedicine, nanotoxicology, emerging nanostructures, nano-cell interaction, biological effect
Citation: Jia J, Mu Q and Zhou H (2023) Editorial: Biomedical applications and health impacts of emerging nanostructured materials. Front. Bioeng. Biotechnol. 11:1282946. doi: 10.3389/fbioe.2023.1282946
Received: 25 August 2023; Accepted: 28 August 2023;
Published: 01 September 2023.
Edited and reviewed by:
Gianni Ciofani, Italian Institute of Technology (IIT), ItalyCopyright © 2023 Jia, Mu and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jianbo Jia, amlhamlhbmJvMDNAZ21haWwuY29t; Qingxin Mu, cW11QHV3LmVkdQ==; Hongyu Zhou, aHl6aG91MDAxQDEyNi5jb20=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.